Abstract:The development of coordination compounds with antineoplastic therapeutic properties is currently focused on non-covalent interactions with deoxyribonucleic acid (DNA). Additionally, the interaction profiles of these compounds with globular plasma proteins, particularly serum albumin, warrant thorough evaluation. In this study, we report on the interactions between biomolecules and complexes featuring hydrazone-type imine ligands coordinated with vanadium. The potential to enhance the therapeutic efficiency of these compounds through mitochondrial targeting is explored. This targeting is facilitated by the derivatization of ligands with triphenylphosphonium groups. Thus, this work presents the synthesis, characterization, interactions, and cytotoxicity of dioxidovanadium( V ) complexes ( C1–C5 ) with a triphenylphosphonium moiety. These V V -species are coordinated to hydrazone-type iminic ligands derived from (3-formyl-4-hydroxybenzyl)triphenylphosphonium chloride ( [AH]Cl ) and aromatic hydrazides ( [H 2 L1]Cl–[H 2 L5]Cl ). The structures of the five complexes were elucidated through single-crystal X-ray diffraction and vibrational spectroscopies, confirming the presence of dioxidovanadium( V ) species in various geometries with degrees of distortion ( τ = 0.03–0.50) and highlighting their zwitterionic characteristics. The molecular structural stability of C1–C5 in solution was ascertained using 1 H, 19 F, 31 P, and 51 V-nuclear magnetic resonance. Moreover, their interactions with biomolecules were evaluated using diverse spectroscopic methodologies and molecular docking, indicating moderate interactions ( K b ≈ 10 4 M −1 ) with calf thymus DNA in the minor groove and with human serum albumin, predominantly in the superficial IB subdomain. Lastly, the cytotoxic potentials of these complexes were assessed in keratinocytes of the HaCaT lineage, revealing that C1–C5 induce a reduction in metabolic activity and cell viability through apoptotic pathways.

Influence of the secondary ligand, phenanthroline, on the antioxidant and pro- oxidant and cytotoxic effects of the oxidovanadium(IV)/naringin complex

Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin

Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells

High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium

Effects of the tetravanadate [V4O12]4− anion on the structural, magnetic, and biological properties of copper/phenanthroline complexes

Vanadium(v) complexes derived from triphenylphosphonium and hydrazides: cytotoxicity evaluation and interaction with biomolecules

Relationship between Antioxidant Activity and Ligand Basicity in the Dipicolinate Series of Oxovanadium(IV) and Dioxovanadium(V) Complexes

Structural and theoretical exploration of an innovative unsymmetrical oxovanadium complex: Electrochemical analysis and in vitro antibacterial screening

Integrated quantum chemical calculations, predictive toxicity assessment, absorption, distribution, metabolism, excretion and toxicity profiling and molecular docking analysis to unveil the therapeutic potential of non‐oxovanadium(IV) and organotin(IV) complexes targeting breast cancer cells

Halogenated Non-Innocent Vanadium(V) Schiff base complexes: chemical and anti-proliferative properties

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

Cytotoxicity, genotoxicity and mutagenicity of mixed ternary mononuclear Mg complex based on valproic acid with 1,10‐phenanthroline in Saccharomyces cerevisiae and V79 cells

Binuclear VIV/V, MoVI and ZnII - hydroquinonate complexes: Synthesis, stability, oxidative activity and anticancer properties

New Oxidovanadium Complexes Incorporating Thiosemicarbazones And 1, 10-Phenanthroline Derivatives As Dna Cleavage, Potential Anticancer Agents, And Hydroxyl Radical Scavenger

Synthesis, Characterization, and Biological Evaluation of Novel Naringenin Derivatives as Anticancer Agents

New Oxidovanadium Complexes Incorporating Thiosemicarbazones and 1, 10‐phenanthroline Derivatives As DNA Cleavage, Potential Anticancer Agents, and Hydroxyl Radical Scavenger

Synthesis, characterization, crystal structure, molecular docking of o-vanillin and L-valine Derived molecules: DFT study and antiproliferative activity against PANC-1 Cancer cell line

Oxidovanadium(V) complexes with chiral tetradentate Schiff bases: Synthesis, spectroscopic characterization, catalytic and biological activity

Synthesis, structural characterization and cytoprotective activity of a new mixed oxidovanadium(IV) compound with nitrilotriacetate and imidazole ligands

Modulating anti-inflammatory and anticancer properties by designing a family of metal-complexes based on 5-nitropicolinic acid

Insights into the Theranostic Activity of Nonoxido VIV: Lysosome-Targeted Anticancer Metallodrugs